We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Aortic Valve System Minimizes Paravalvular Leakage

By HospiMedica International staff writers
Posted on 06 May 2019
Print article
Image: The LOTUS Edge aortic valve system (Photo courtesy of Boston Scientific).
Image: The LOTUS Edge aortic valve system (Photo courtesy of Boston Scientific).
A new transcatheter aortic valve replacement (TAVR) system for patients with severe stenosis offers controlled delivery and repositionability.

The Boston Scientific (Natick, MA, USA) LOTUS Edge aortic valve system features a proprietary braided Nickel-Titanium (Nitinol) frame and an adaptive seal technology that conforms to patients’ anatomy in order to create a secure seal, virtually eliminating paravalvular leak (PVL). The system is designed for strength, flexibility, and complete control during placement to ensure precise, stable, deployment and reduced procedural complications. The deployment technology also allows easy retrieval, repositioning, and redeployment.

Additional features include bovine pericardium lining materials, a flexible delivery catheter that helps improve trackability, proprietary depth guard technology designed to reduce left ventricular outflow tract (LVOT) interaction and permanent pacemaker (PPM) rates by minimizing the depth of the valve during deployment, and radiopaque markers that enable the operator to confirm locking in one view. LOTUS Edge is available in 23, 25, and 27 mm outer diameters and a standard height of 19 mm.

“Bringing the much-anticipated LOTUS Edge valve system to market allows us to provide patients who aren't good candidates for traditional surgery a safe and effective treatment alternative to restore proper function to their severely narrowed aortic valve,” said Kevin Ballinger, executive VP and global president of interventional cardiology at Boston Scientific. “This technology is a fundamental component of our expanding portfolio and demonstrates our continuing commitment to category leadership within the fast-growing structural heart treatment landscape.”

Aortic valve disease results in dysfunction of the aortic valve, one of the four valves that control the flow of blood in and out of the heart. It is the most common valvular heart disease in the world, affecting approximately seven percent of the population over age 65. TAVR prosthetic aortic valve replacement, without the need for open heart surgery or cardiopulmonary bypass, has proven effective in high-risk and inoperable patients, and could soon become the standard of care, even in moderate and low surgical risk patients.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bilirubin Lamp
Bilibluelight

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.